ANNX Annexon Inc

Price (delayed)

$5.19

Market cap

$276.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.81

Enterprise value

$173.63M

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on ...

Highlights
Annexon's EPS has increased by 46% YoY and by 4.2% QoQ
Annexon's debt has decreased by 7% YoY
The equity has declined by 40% year-on-year and by 15% since the previous quarter
Annexon's quick ratio has decreased by 28% YoY and by 11% from the previous quarter

Key stats

What are the main financial stats of ANNX
Market
Shares outstanding
53.24M
Market cap
$276.31M
Enterprise value
$173.63M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.76
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$140.73M
EBITDA
-$137.28M
Free cash flow
-$125.27M
Per share
EPS
-$1.81
Free cash flow per share
-$1.66
Book value per share
$2.95
Revenue per share
$0
TBVPS
$2.71
Balance sheet
Total assets
$203.82M
Total liabilities
$46.98M
Debt
$31.51M
Equity
$156.84M
Working capital
$152M
Liquidity
Debt to equity
0.2
Current ratio
9.85
Quick ratio
9.69
Net debt/EBITDA
0.75
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-56.8%
Return on equity
-71.5%
Return on invested capital
-111.6%
Return on capital employed
-75.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANNX stock price

How has the Annexon stock price performed over time
Intraday
1.17%
1 week
3.59%
1 month
19.59%
1 year
-12.77%
YTD
14.32%
QTD
14.32%

Financial performance

How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$150.41M
Net income
-$140.73M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 2.9% YoY
The company's operating income fell by 2.8% YoY

Growth

What is Annexon's growth rate over time

Valuation

What is Annexon stock price valuation
P/E
N/A
P/B
1.76
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has increased by 46% YoY and by 4.2% QoQ
The P/B is 96% higher than the last 4 quarters average of 0.9
The equity has declined by 40% year-on-year and by 15% since the previous quarter

Efficiency

How efficient is Annexon business performance
The return on invested capital has declined by 19% year-on-year and by 4.1% since the previous quarter
The ROE has declined by 11% since the previous quarter and by 6% year-on-year
ANNX's ROA is down by 9% QoQ and by 5% YoY

Dividends

What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANNX.

Financial health

How did Annexon financials performed over time
ANNX's total assets is down by 35% year-on-year and by 13% since the previous quarter
Annexon's current ratio has decreased by 28% YoY and by 11% from the previous quarter
Annexon's debt is 80% less than its equity
The debt to equity has surged by 54% year-on-year and by 18% since the previous quarter
The equity has declined by 40% year-on-year and by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.